Evidence map›Paper›PMID 34959274›Full record

ArticlePharmaceutics2021

Compartmentalized Polymeric Nanoparticles Deliver Vancomycin in a pH-Responsive Manner.

Merve Seray Ural, Mario Menéndez-Miranda, Giuseppina Salzano, Jérémie Mathurin, Ece Neslihan Aybeke, Ariane Deniset-Besseau, Alexandre Dazzi, Marianna Porcino, Charlotte Martineau-Corcos, Ruxandra Gref

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Merve Seray UralInstitut de Sciences Moléculaires d'Orsay, CNRS UMR 8214, Université Paris-Sud, Université Paris-Saclay, 91405 Orsay, France.
Mario Menéndez-MirandaInstitut de Sciences Moléculaires d'Orsay, CNRS UMR 8214, Université Paris-Sud, Université Paris-Saclay, 91405 Orsay, France.
Giuseppina SalzanoInstitut de Sciences Moléculaires d'Orsay, CNRS UMR 8214, Université Paris-Sud, Université Paris-Saclay, 91405 Orsay, France.
Jérémie MathurinInstitut de Chimie Physique, CNRS UMR 8000, Université Paris Sud, Université Paris-Saclay, 91405 Orsay, France.ORCID 0000-0002-6769-6394
Ece Neslihan AybekeInstitut de Chimie Physique, CNRS UMR 8000, Université Paris Sud, Université Paris-Saclay, 91405 Orsay, France.
Ariane Deniset-BesseauInstitut de Chimie Physique, CNRS UMR 8000, Université Paris Sud, Université Paris-Saclay, 91405 Orsay, France.
Alexandre DazziInstitut de Chimie Physique, CNRS UMR 8000, Université Paris Sud, Université Paris-Saclay, 91405 Orsay, France.
Marianna PorcinoConditions Extrêmes et Matériaux: Haute Température et Irradiation (CEMHTI), CNRS UPR 3079, Université d'Orléans, 45071 Orléans, France.
Charlotte Martineau-CorcosConditions Extrêmes et Matériaux: Haute Température et Irradiation (CEMHTI), CNRS UPR 3079, Université d'Orléans, 45071 Orléans, France.
Ruxandra GrefInstitut de Sciences Moléculaires d'Orsay, CNRS UMR 8214, Université Paris-Sud, Université Paris-Saclay, 91405 Orsay, France.ORCID 0000-0002-7869-0908
Université Paris-Sud · FRUniversité d'Orléans · FR

Funding

Agence Nationale de la Recherche ANR-10-LABX-0035Agence Nationale de la Recherche ANR-16-CE18-0018
6 · The paper itself

Abstract

Vancomycin (VCM) is a last resort antibiotic in the treatment of severe Gram-positive infections. However, its administration is limited by several drawbacks such as: strong pH-dependent charge, tendency to aggregate, low bioavailability, and poor cellular uptake. These drawbacks were circumvented by engineering pH-responsive nanoparticles (NPs) capable to incorporate high VCM payload and deliver it specifically at slightly acidic pH corresponding to infection sites. Taking advantage of peculiar physicochemical properties of VCM, here we show how to incorporate VCM efficiently in biodegradable NPs made of poly(lactic-co-glycolic acid) and polylactic acid (co)polymers. The NPs were prepared by a simple and reproducible method, establishing strong electrostatic interactions between VCM and the (co)polymers' end groups. VCM payloads reached up to 25 wt%. The drug loading mechanism was investigated by solid state nuclear magnetic resonance spectroscopy. The engineered NPs were characterized by a set of advanced physicochemical methods, which allowed examining their morphology, internal structures, and chemical composition on an individual NP basis. The compartmentalized structure of NPs was evidenced by cryogenic transmission electronic microscopy, whereas the chemical composition of the NPs' top layers and core was obtained by electron microscopies associated with energy-dispersive X-ray spectroscopy. Noteworthy, atomic force microscopy coupled to infrared spectroscopy allowed mapping the drug location and gave semiquantitative information about the loadings of individual NPs. In addition, the NPs were stable upon storage and did not release the incorporated drug at neutral pH. Interestingly, a slight acidification of the medium induced a rapid VCM release. The compartmentalized NPs could find potential applications for controlled VCM release at an infected site with local acidic pH.

Indexed as

antibioticbiodegradable polymercontrolled releasedrug locationnanoparticlevancomycin

Identifiers

PMID34959274
PMCPMC8709497
OpenAlexW3216479621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.